| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) | 
|---|
| 08/19/1997 | US5658939 Prevention thrombosis in mammals | 
| 08/19/1997 | US5658935 Useful as inhibitors of thrombocyte aggregation, the metastasis of carcinoma cells and the binding of osteoclasts on bone surfaces | 
| 08/19/1997 | US5658933 Enzyme inhibitors of proline and lysine hydroxylases necessary for the biosynthesis of collagen; antifibrotic agents; respiratory, liver and skin disorders; atherosclerosis; antiscarring agents | 
| 08/19/1997 | US5658930 Thrombin inhibitors | 
| 08/19/1997 | US5658908 Opioid diarylmethylpiperazines and piperdines | 
| 08/19/1997 | US5658885 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes | 
| 08/19/1997 | US5658872 Biodegradable complexing agent | 
| 08/17/1997 | CA2197611A1 Pseudopeptides derives from neurokinins and their preparation process | 
| 08/14/1997 | WO1997029122A1 (N)-(S)-1-PHENYL-1-ALKANAMIDE (N)-(3,3-DIMETHYLBUTYL)-L-ASPARTYL-D-α AMINOALKANOIC ACID FOR USE AS A SWEETENER | 
| 08/14/1997 | WO1997029121A1 Application of ureidoacetamides to the preparation of medicaments intended to the treatment of the abuse of drugs or substances giving rise to pharmacomania or to an excessive use | 
| 08/14/1997 | WO1997029096A1 Micacocidin derivatives | 
| 08/14/1997 | DE19605039A1 High yield and purity production of reversibly protected oligopeptide aldehyde | 
| 08/14/1997 | CA2245898A1 (n)-(s)-1-phenyl-1-alkanamide (n)-(3,3-dimethylbutyl)-l-aspartyl-d-.alpha. aminoalkanoic acid for use as a sweetener | 
| 08/13/1997 | EP0789030A1 Fibrinogen binding peptides | 
| 08/13/1997 | EP0788510A1 Dipeptide derivatives, process for producing them and medicaments containing these compounds | 
| 08/13/1997 | EP0788509A1 Therapeutic peptide derivatives | 
| 08/13/1997 | EP0788360A1 Boronic ester and acid compounds, synthesis and uses | 
| 08/13/1997 | EP0659175B1 Optically active alkylammonium (amino-3 phenyl)-1 ethanesulfonate derivatives, preparation and use thereof | 
| 08/13/1997 | CN1156965A Cytokine regulatory agents and method of use in pathologies and conditions associated with altered cytokine levels | 
| 08/13/1997 | CN1035616C 异羟肟酸衍生物 Hydroxamic acid derivatives | 
| 08/12/1997 | US5656651 Androgenic directed compositions | 
| 08/12/1997 | US5656645 Aromatic heterocyclic derivatives as enzyme inhibitors | 
| 08/12/1997 | US5656627 Inhibitors of interleukin-1β converting enzyme | 
| 08/12/1997 | US5656604 Peptide compound and its preparation | 
| 08/12/1997 | US5656603 Aminopeptidase P inhibitors and uses thereof | 
| 08/12/1997 | US5656600 Modified polypeptides | 
| 08/12/1997 | US5656456 Chemical method for selective modification of the N- and/or C-terminal amino acid α-carbon reactive group of a recombinant polypeptide or a portion thereof | 
| 08/12/1997 | CA2197264A1 Process for preparing oligopeptide aldehydes | 
| 08/07/1997 | WO1997028276A1 Measurement of complement activation by biomaterials by means of complement convertase cleavage of peptide substrates | 
| 08/07/1997 | WO1997028184A1 Method of treating beta-amyloid peptide associated conditions using trh | 
| 08/07/1997 | WO1997028183A1 Peptide inhibitors of hematopoietic cell proliferation | 
| 08/07/1997 | WO1997019106A3 Collagen-like peptoid residue-containing structures | 
| 08/07/1997 | DE19604225A1 Composition comprises cyclo-hexen-beta-amino acid and alpha-amino acid | 
| 08/07/1997 | CA2245145A1 Method of treating beta-amyloid peptide associated conditions using trh | 
| 08/07/1997 | CA2244673A1 Peptide inhibitors of hematopoietic cell proliferation | 
| 08/06/1997 | EP0787143A2 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides | 
| 08/06/1997 | EP0787137A2 Method for peptide synthesis based on n-(n'-nitrosocarbamoyl)amino acids | 
| 08/06/1997 | EP0787123A1 Inhibitors of farnesyl-protein transferase | 
| 08/06/1997 | EP0787010A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes | 
| 08/06/1997 | EP0787009A1 Cancer inhibitory peptides | 
| 08/06/1997 | EP0585397B1 Bombesin analogs | 
| 08/06/1997 | CN1155995A Sweetener salt | 
| 08/05/1997 | US5654400 Process for making peptide compounds having tachykinin antagonistic activity | 
| 08/05/1997 | US5654399 Tetrapeptide derivative having antitumor activity | 
| 08/05/1997 | US5654294 Spiro lactam dual action inhibitors | 
| 08/05/1997 | US5654282 Antiinflammatory agents; viricides; anticancer agents | 
| 08/05/1997 | US5654277 Inhibiting tumor metastasis in mammals by administering specific tetra- or pentapeptides | 
| 08/05/1997 | US5654272 Including an amino acid sequence of cysteine-(amino acid)-cysteine to complex the isotope and a target binding sequencefor target sites including atherosclerotic plaque and alzheimer's amyloid plaque; scintigraphy | 
| 08/05/1997 | CA1339205C Oligonucleotide-polyamide conjugates | 
| 08/02/1997 | CA2196368A1 Fibrinogen binding peptides | 
| 07/31/1997 | WO1997027315A1 Combinatorial hydroxypropylamine library | 
| 07/31/1997 | WO1997027220A2 Substrates and inhibitors for cysteine protease ich-1 | 
| 07/31/1997 | CA2243568A1 Combinatorial hydroxypropylamine library | 
| 07/31/1997 | CA2243497A1 Substrates and inhibitors for cysteine protease ich-1 | 
| 07/30/1997 | EP0786471A1 Arthrichitin, a process for its production and its use | 
| 07/30/1997 | EP0786470A1 Peptide compound | 
| 07/30/1997 | EP0786469A2 Nucleic acid ligands | 
| 07/30/1997 | EP0786002A1 Intracellular isoform of the interleukin-1 receptor antagonist | 
| 07/30/1997 | EP0785945A1 New peptides with immunomodulatory effects | 
| 07/30/1997 | EP0785944A1 Acyl amino acetamide derivatives with agonist activity for cck-a receptors | 
| 07/30/1997 | EP0785784A1 4-heterocyclic piperidines promote release of growth hormone | 
| 07/30/1997 | EP0785713A1 Creating an aerosolized formulation of insulin | 
| 07/30/1997 | CN1155905A Crosslinked polyacrylamide gels with high monomer crosslinker ratios | 
| 07/29/1997 | US5652369 Amino acid derivatives | 
| 07/29/1997 | US5652334 Method for design of substances that enhance memory and improve the quality of life | 
| 07/29/1997 | US5652257 Anticarcinogenic | 
| 07/29/1997 | US5652235 Method of using spiro piperidines to promote the release of growth hormone | 
| 07/29/1997 | US5652211 Treatment of septic shock | 
| 07/24/1997 | WO1997025999A1 Peptides for altering osteoblast adhesion | 
| 07/24/1997 | WO1997018207A3 Novel macrocyclic compounds as metalloprotease inhibitors | 
| 07/24/1997 | CA2242911A1 Peptides for altering osteoblast adhesion | 
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof | 
| 07/23/1997 | EP0784629A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases | 
| 07/23/1997 | EP0784628A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME | 
| 07/23/1997 | EP0784469A1 Compositions for the delivery of antigens | 
| 07/23/1997 | EP0554400B1 Retroviral protease inhibitors | 
| 07/23/1997 | CN1155248A Somatostatin binding peptide-metal chelate conjugates | 
| 07/23/1997 | CN1155245A Use of muramyl peptide compounds | 
| 07/22/1997 | US5650538 Organic salts of N,N'-diacetyl cystine | 
| 07/22/1997 | US5650508 Inhibitors of serine and cysteine proteases | 
| 07/22/1997 | US5650408 Thiazolo benzazepine containing dual action inhibitors | 
| 07/22/1997 | US5650393 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems | 
| 07/22/1997 | US5650292 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them | 
| 07/17/1997 | WO1997025418A1 Angiotensin converting enzyme inhibitors | 
| 07/17/1997 | WO1997025351A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR | 
| 07/17/1997 | WO1997025342A1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione | 
| 07/17/1997 | WO1997025315A1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity | 
| 07/17/1997 | CA2241169A1 Inhibitors of madcam-1-mediated interactions and methods of use therefor | 
| 07/16/1997 | EP0784058A1 Derivatives of aspartic acid, preparation and use thereof | 
| 07/16/1997 | EP0783521A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone | 
| 07/16/1997 | EP0783519A1 New peptides with immunomodulatory effects | 
| 07/16/1997 | EP0783518A1 Inhibitors of farnesyl-protein transferase | 
| 07/16/1997 | EP0783517A2 Thiol-free inhibitors of farnesyl-protein transferase | 
| 07/16/1997 | EP0783515A2 Protective and linking groups and their use (carbamides) | 
| 07/16/1997 | EP0783489A1 Aldehyde derivatives as upsteine protease inhibitors | 
| 07/16/1997 | EP0783319A1 Muramyl peptide compositions for inhibiting hiv replication | 
| 07/16/1997 | EP0783318A1 Inhibitors of farnesyl-protein transferase | 
| 07/16/1997 | EP0783316A1 Synthetic antibiotics | 
| 07/16/1997 | EP0783305A1 Inhibitors of farnesyl-protein transferase | 
| 07/16/1997 | EP0783299A1 Compounds and compositions for delivering active agents |